发明名称 MESALAMINE SUPPOSITORY
摘要 The present invention relates to a mesalamine rectal suppository designed to provide improved comfort of use. One embodiment of the invention is a mesalamine rectal suppository-comprising mesalamine and one or more pharmaceutically acceptable excipients, wherein the drug load of the suppository ranges from 35% to 50%. Yet another embodiment of the invention is a mesalamine rectal suppository comprising mesalamine having a tap density ranging from about 600 to about 800 g/L (as measured by USP <616>) and a hard fat having an ascending melting point of 32 to 35.5� C. Yet another embodiment is a mesalamine rectal suppository comprising mesalamine particles and one or more pharmaceutically acceptable excipients, where the mesalamine particles have a surface area of from about 0.1 m2/g to about 2.8 m2/g (e.g., from about 0.1 m2/g to about 1.3 m2/g). Methods of preparing and methods of treatment with mesalamine suppositories are also provided. The invention further provides a method of determining a dissolution parameter (such as dissolution rate) of a mesalamine rectal suppository, such as a 1 g mesalamine suppository, by measuring its dissolution with USP Apparatus #2 at 40� C. and a paddle rotation speed of 125 rpm in 0.2 M phosphate buffer at a pH of 7.5.
申请公布号 US2013231310(A1) 申请公布日期 2013.09.05
申请号 US201313859898 申请日期 2013.04.10
申请人 APTALIS PHARMA CANADA INC. 发明人 GAUTHIER CARL;DUMOULIN YVES;POWELL DAVID;MOREAU HUGUES
分类号 A61K9/14;A61K9/00;A61K47/44 主分类号 A61K9/14
代理机构 代理人
主权项
地址
您可能感兴趣的专利